Recent advances in the treatment of pulmonary artery hypertension

ACC Current Journal Review

Volumn 7, Issue 6, 1998, Pages 60-64

  Barst, Robyn J ^a,b  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^b NewYork Presbyterian Columbia University Irving Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CARDIAC GLYCOSIDE; DIURETIC AGENT; NITRIC OXIDE; PROSTACYCLIN; VASODILATOR AGENT;

ANTICOAGULANT THERAPY; CHILD; DISEASE CLASSIFICATION; HEART LUNG TRANSPLANTATION; HUMAN; HYPERTENSION; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; OXYGEN THERAPY; PULMONARY ARTERY; PULMONARY HYPERTENSION; SHORT SURVEY; SURVIVAL RATE; THROMBOSIS PREVENTION; VASODILATATION;

EID: 0032214218     PISSN: 10621458     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1062-1458(98)00066-X     Document Type: Article

References (12)

1. Kidd L., Driscoll D.J., Gersony W.M., et al. Second natural history study of congenital heart defects Results of treatment of patients with ventricular septal defects . Circulation. 87:1993;38-51.
2. Roberts J.D. Jr, Lan P., Bigatello L.M., Vlahakes G.J., Zapol W.M. Inhaled nitric oxide in congenital heart disease. Circulation. 87:1993;447-453.
3. Bush A., Busst C., Knight W.B., Shinebourne E.A. Modification of pulmonary hypertension secondary to congenital heart disease by prostacyclin therapy. Am Rev Respir Dis. 136:1987;767-769.
4. Barst RJ, Maislin G, Fishman AP. Vasodilator therapy in primary pulmonary hypertension in children. Circulation 1998 (in press).
5. Rich S., Kaufmann E., Levy P.S. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med. 327:1992;76-81.
6. Barst R.J., Rubin L.J., Long W.A., et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med. 334:1996;296-301.
7. Channick R.N., Newhart J.W., Johnson F.W., et al. Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension An ambulatory delivery system and initial clinical tests . Chest. 109:1996;1545-1549.
8. McLaughlin V.V., Genthner D.E., Panella M.M., Rich S. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N Engl J Med. 338:1998;273-277.
9. Berman-Rosenzweig E, Kerstein D, Barst RJ. Chronic prostacyclin therapy for pulmonary hypertension with associated congenital heart defects. Circulation 1998 (in press).
10. Hausknecht M.J., Sims R.E., Nihill M.R., Cashion W.R. Successful palliation of primary pulmonary hypertension by atrial septostomy. Am J Cardiol. 675:1990;1045-1046.
11. Kerstein D., Levy P.S., Hsu D.T., Hordorf A.J., Gersony W.M., Barst R.J. Blade balloon atrial septostomy improves survival in patients with severe primary pulmonary hypertension. Circulation. 91:1995;2028-2035.
12. Pasque M.K., Trulock E.P., Cooper J.D., et al. Single lung transplantation for pulmonary hypertension Single institution experience in 34 patients . Circulation. 92:1995;2252-2258.